CD163 and dementia: Markers of monocyte activation, such as monocyte differentiation antigen CD14 (sCD14), associate with increased risk for incident dementia, and with cognitive function and brain MRI markers of brain aging in two community based cohorts [4], while soluble CD163 is elevated in inflammatory diseases [5] and subarachnoid hemorrhage [6].